Headlines about TrueBlue (NYSE:TBI) have been trending somewhat positive this week, Accern reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. TrueBlue earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave news stories about the business services provider an impact score of 45.8235651739164 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

TrueBlue (TBI) opened at 20.10 on Thursday. The stock has a market cap of $835.72 million, a PE ratio of 14.19 and a beta of 2.34. The stock’s 50 day moving average is $23.31 and its 200 day moving average is $25.67. TrueBlue has a 52 week low of $16.50 and a 52 week high of $28.70.

TrueBlue (NYSE:TBI) last issued its earnings results on Monday, July 31st. The business services provider reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The company had revenue of $610.10 million for the quarter, compared to analyst estimates of $610.04 million. TrueBlue had a net margin of 2.27% and a return on equity of 15.18%. The business’s revenue was down 9.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.54 EPS. Analysts predict that TrueBlue will post $1.69 EPS for the current year.

TBI has been the topic of several research reports. BMO Capital Markets restated a “sell” rating and issued a $25.00 target price on shares of TrueBlue in a report on Wednesday, May 3rd. Zacks Investment Research cut shares of TrueBlue from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. BidaskClub cut shares of TrueBlue from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Finally, TheStreet upgraded shares of TrueBlue from a “c” rating to a “b” rating in a research note on Monday, July 31st. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $21.25.

COPYRIGHT VIOLATION WARNING: “TrueBlue (TBI) Receives Daily News Impact Rating of 0.15” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/trueblue-tbi-receives-daily-news-impact-rating-of-0-15/1533340.html.

In other TrueBlue news, CFO Derrek Lane Gafford sold 20,000 shares of the business’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $27.75, for a total transaction of $555,000.00. Following the sale, the chief financial officer now directly owns 91,859 shares in the company, valued at approximately $2,549,087.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Joseph P. Sambataro, Jr. sold 25,000 shares of the business’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $28.32, for a total transaction of $708,000.00. Following the sale, the director now owns 73,581 shares in the company, valued at $2,083,813.92. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

TrueBlue Company Profile

TrueBlue, Inc is a provider of specialized workforce solutions. The Company is engaged in providing staffing, on-site workforce management and recruitment process outsourcing services. The Company operates through three segments: PeopleReady, PeopleManagement and PeopleScout. Its PeopleReady segment provides blue-collar contingent staffing through the PeopleReady service line.

Insider Buying and Selling by Quarter for TrueBlue (NYSE:TBI)

Receive News & Ratings for TrueBlue Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.